Phase 3 Ocular Hypertension trials recruiting now

All Ocular Hypertension trials, every phase

Other phases for Ocular Hypertension

Phase 3 Ocular Hypertension trials

• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
  NCT05401357 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
  NCT07335211 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
  NCT07218783 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · 1 location
• Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
  NCT07218796 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · 1 location
• [KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
  NCT07662759 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.